Skip to content

NuScale Power SMR Cost share obligation, amount

Cost share obligation, amount at other companies

StepStone Group Inc. logo
StepStone Group Inc.STEP
$1.33M-35.1%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
50%
Raytheon Technologies logo
Raytheon TechnologiesRTX
$0.250.0%
Biogen logo
BiogenBIIB
7.5%
Biogen logo
BiogenBIIB
$72.55M+14.1%
Medline, Inc.
 logo
Medline, Inc. MDLN
$21M

Other financials

Income statement

See full
Revenue$565.0K-95.8%
Gross profit$21.0K-99.7%
Operating income-$57.5M-62.8%
Net income-$44.0M-214%
EPS (diluted)-$0.14-27.3%

Balance sheet

See full
Cash & equivalents$346.2M-30.3%
Total debt$5.7M
Total equity$1.2B+65.7%
Total assets$1.1B+85.8%

Cash flow

See full
Operating cash flow-$314.7M-1,281%
CapEx$1.5M+2,172%
Free cash flow-$316.2M-1,284%

Valuation

See full
Market cap$3.76B+90.3%

Profitability

See full
Gross margin24.2%-54.3pp
Operating margin-3,812.6%-4,121pp
Net margin-2,066.5%-2,438pp
FCF margin-200%-88.0pp

Returns & leverage

See full
Return on equity-41.2%+15.7pp
Debt / equity
Current ratio29.4×+23.1×

Where this comes from

Reported directly by NuScale Power in its filing.

Tagged under the XBRL concept smr:CostShareObligationAmount.

The official record: NuScale Power’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuScale Power's cost share obligation, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuScale Power's cost share obligation, amount?
NuScale Power (SMR) reported cost share obligation, amount of $7.07M in Q1 2026.
How has NuScale Power's cost share obligation, amount changed year-over-year?
NuScale Power's cost share obligation, amount decreased by 3.8% year-over-year, from $7.35M to $7.07M.
What does cost share obligation, amount mean?
This represents the company's portion of shared project costs or joint development funding requirements as stipulated in collaborative agreements or government-backed initiatives. It highlights the financial burden associated with co-funded research, development, or infrastructure projects. Monitoring this amount is essential for evaluating the company's capital allocation strategy and the sustainability of its partnership-based business model.